Skip to main navigation
logo

Site - Investor Relations

  • Overview
  • News & Events
    • Press Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
  • Corporate Governance
    • Documents & Charters
    • Leadership Team
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials & Filings
    • SEC Filings
    • Annual Reports
    • Quarterly Results
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact IR

Press Releases

July 25, 2022 - Ginkgo to Acquire Zymergen
PDF Version
July 14, 2022 - Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform
PDF Version
June 28, 2022 - Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications
PDF Version
May 26, 2022 - Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform
PDF Version
May 12, 2022 - Zymergen Reports Preliminary First Quarter 2022 Financial Results
PDF Version
April 29, 2022 - Zymergen to Participate in the BofA Securities 2022 Healthcare Conference
PDF Version
April 13, 2022 - Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022
PDF Version
March 22, 2022 - Zymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results
PDF Version
March 16, 2022 - Zymergen to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on March 22nd, 2022
PDF Version
March 6, 2022 - Zymergen Advances Molecules for Prominent Malaria and COVID-19 Drug Targets for Further Testing
PDF Version

Pagination

  • Current page 1
  • Page 2
  • Next page next ›
  • Last page last »
Displaying 1 - 10 of 14

Site - Shareholder Tools

  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact IR

© 2023 Zymergen.     All rights reserved.